PITTSBURGH (KDKA) -- Cluster headaches can be just as bad as migraines and just as difficult to treat. But the Food and Drug Administration has just approved the first drug to not only treat, but also ...

(Reuters Health) - Two drug trials may promise some relief for people who suffer migraine headaches as well as those who have cluster headaches, a rare but intensely painful type of headache thought ...

Earlier this month, the FDA approved the first ever migraine drug, galcanezumab-gnlm (Emgality, Lilly) indicated to treat cluster headaches. Earlier this month, the FDA approved the first ever ...

NICE has today published a medical technologies guidance document recommending the use of gammaCore within the NHS for the acute and preventive treatment of cluster headache in the U.K. The guidance ...

A cluster headache is a rare type of headache that occurs suddenly and causes pain in one side of the head, often in the eye area. The name cluster headache comes from the tendency of these headaches ...

Prior to initiating Brekiya, a cardiovascular evaluation is recommended. Brekiya ®, a ready-to-use dihydroergotamine (DHE) autoinjector, is now available for the acute treatment of migraine with or ...

INDIANAPOLIS, June 4, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Emgality ® (galcanezumab-gnlm) injection (300 ...